A revolutionary wearable that replaces complex belts and cannulas with a single acoustic sensor for high-accuracy, automated OSA diagnosis.

AcuPebble SA100 Review: Acoustic Innovation in Home Sleep Apnea Testing

Published Mar 24, 2026
|
Reviewed by Dr. Swapna Mandal, MBBS, MRCP, PhD, MD
|
Testing 30 days
|
Evidence Strong Clinical Evidence
PEER REVIEWED

The AcuPebble SA100, developed by Acurable, introduces a novel approach to home sleep apnea testing by utilizing acoustic sensing technology. Instead of traditional channels like nasal airflow or finger pulse oximetry, the device is a single 7-gram sensor attached to the suprasternal notch of the neck with medical adhesive. It records the physiological sounds generated by respiratory and cardiac functions, which are then processed by patented algorithms to derive key diagnostic parameters including the Apnea-Hypopnea Index (AHI) and Oxygen Desaturation Index (ODI). A landmark study published in BMJ Open demonstrated that the AcuPebble SA100 achieved a 95.33% diagnostic accuracy when compared against gold-standard polygraphy. The system is entirely automated; patients follow instructions via a mobile app, upload their data to the cloud, and a clinically validated report is generated instantly for the healthcare provider.

Recommended Strong Clinical Evidence FDA 510(k) Cleared
AcuPebble SA100 Home Sleep Test - Medical Device

AcuPebble SA100 Home Sleep Test

Acurable

92 /100

Our Score

Clinical Performance Metrics

Quantitative assessment based on clinical testing protocols

Diagnostic Accuracy

Clinical trials reported 92.7% sensitivity and 96.8% specificity for identifying sleep apnea compared to standard diagnostic pathways.

93/100

Ease of Use

Acurable's trials showed 100% of patients were able to successfully complete the test without training or assistance.

98/100

Wearing Comfort

The ultra-lightweight 7g sensor is non-invasive and allows for a more natural sleep environment compared to traditional belt systems.

92/100

Value for Money

While the upfront cost is significant, the reduction in clinical interpretation time and high diagnostic yield provide strong ROI for health systems.

85/100

Quick Take

Key findings from our clinical evaluation

+
Strengths

  • Breakthrough wire-free design using a single miniature neck sensor
  • High diagnostic accuracy equivalent to cardiorespiratory polygraphy
  • Zero user training required with 100% test completion rate in trials
  • Fully automated clinical reporting minimizes physician interpretation time
  • Detects both respiratory and cardiac disease biomarkers via acoustics

Limitations

  • Requires medical adhesive which may cause localized skin sensitivity
  • Does not record neurological channels for direct sleep staging (EEG)
  • Currently not validated for patients with congestive heart failure or neuromuscular disorders

Real-World Usage

Practical considerations for daily operation

Daily Routine Impact

Setup is as simple as peeling off an adhesive and placing the 'pebble' on the neck. Users can sleep naturally in any position without wires or belts interfering with their routine.

Learning Curve

Use right out of the box

Maintenance

The sensor must be charged before use and cleaned/disinfected between patients; adhesives are single-use only.

Portability

Exceptional; the 7g sensor is the smallest diagnostic HST available and easily portable for remote testing.

Manual Use

N/A; the device requires the companion mobile application to initiate and process the diagnostic study.

Cost & Coverage Analysis

Financial considerations and HSA / FSA eligibility

Pricing Breakdown

Medical Adhesive Tape (Single-use double-coated medical tape)
Free
HSA / FSA Eligibility Usually Eligible

HSA/FSA Guidance

Often utilized within the UK NHS diagnostic pathways; US patients should check coverage for Type IV HST codes.

Cost Comparison

Priced competitively with high-end reusable HSTs but offers significant savings in clinical interpretation labor.

Patient Suitability

Clinical indications and contraindications

Indicated For

  • Patients seeking the least invasive home sleep study possible
  • Sleep clinics looking to clear backlogs with automated diagnosis
  • Individuals who struggle with complex sensor hookups or belts

Contraindications

  • Patients requiring detailed EEG-based sleep stage analysis
  • Individuals with unstable cardiac conditions or pacemakers

Age Considerations

FDA cleared for use in adult patients 18 years and older.

Clinical Efficacy Assessment

Evidence-based evaluation of clinical performance

AHI Detection Accuracy

Measures the device's ability to accurately count apnea and hypopnea events per hour.

The device accurately detects apnoea and hypopnoea events by analyzing tracheal sound patterns associated with airway obstructions.

Sleep Stage Identification

Evaluates accuracy in identifying sleep architecture (REM/NREM).

Parameters are obtained using estimation of sleep time rather than neurological EEG channels.

Respiratory Event Detection

Sensitivity in identifying specific respiratory obstructions and effort.

Acoustic effort channels extracted from tracheal sounds have demonstrated high agreement with gold-standard effort measurements.

In-Lab PSG Correlation

Reflects how consistently the device's results align with a full attended hospital sleep study.

Validated against gold-standard PSG with an Intra-class Correlation Coefficient (ICC) of 0.84 to 0.89 for estimated AHI.

Comparative Performance

Ranked #5 of 24 clinically evaluated home sleep tests devices

1
Withings Sleep Analyzer

Withings Sleep Analyzer

Withings

Top Rated
2
Sunrise Home Sleep Test

Sunrise Home Sleep Test

Sunrise SA

3
NightOwl Home Sleep Apnea Test

NightOwl Home Sleep Apnea Test

ResMed

5
AcuPebble SA100 Home Sleep Test

AcuPebble SA100 Home Sleep Test

Acurable

You're viewing this
92 /100

Clinical Context

Our #1-ranked home sleep tests device demonstrated superior performance across key clinical metrics. Compare detailed specifications to make an evidence-based selection.

Clinical Recommendation

Final assessment and prescribing guidance

The AcuPebble SA100 is a masterclass in minimalist diagnostic design. By successfully utilizing acoustics for OSA diagnosis, it provides clinicians with high-quality data while offering patients the most comfortable testing experience available.

Recommend If

You want a clinically accurate, medically recognized sleep study with absolutely no wires, belts, or tubes.

Avoid If

You require a full polysomnography for complex comorbidities like central sleep apnea or neuromuscular disorders.

Clinical Summary

92 /100

Composite Score

Recommended

Recommendation

Evidence: Strong
Tested: 30 days

Where to Buy

Verified purchase options and current availability

Acurable (HCP Inquiry)

Varies by healthcare provider

Prescription required; primarily B2B supply to clinics and hospitals.

Shop Now

Hunrosa Sleep Specialist (UK)

Price: $465.00
3-5 business days

Price includes diagnostic test, clinical report, and specialist consultation (GBP 370).

Shop Now

Important Information

  • • Prices and availability subject to change
  • • Some devices may require a prescription
  • • HSA / FSA eligibility: Usually Eligible
  • • Purchase from authorized retailers for warranty protection
Visit Manufacturer Website

Alternative Devices

AcuPebble provides higher ease-of-use than WatchPAT due to the absence of finger sensors, though both share similar clinical accuracy.

Testing Methodology

Prospective evaluation study comparing automated acoustic diagnosis against expert-scored multichannel cardiorespiratory polygraphy.

Medical Review: Lead investigators have noted that AcuPebble SA100 provides diagnostic equivalence to ambulatory polygraphy while significantly reducing the time required for manual clinical interpretation.

Medical Disclaimer

This review is for informational purposes only and does not constitute medical advice. Individual results may vary. Always consult with healthcare professionals before making medical device decisions. Clinical recommendations should be individualized based on patient-specific factors.